Omics-driven drug repurposing as a source of innovative therapies in rare cancers

MLA

Pan Pantziarka, and Lydie Meheus. “Omics-Driven Drug Repurposing as a Source of Innovative Therapies in Rare Cancers.” Expert Opinion on Orphan Drugs, vol. 6, July 2018, pp. 513–17. EBSCOhost, https://doi.org/10.1080/21678707.2018.1500690.

APA

Pan Pantziarka, & Lydie Meheus. (2018). Omics-driven drug repurposing as a source of innovative therapies in rare cancers. Expert Opinion on Orphan Drugs, 6, 513–517. https://doi.org/10.1080/21678707.2018.1500690

Chicago

Pan Pantziarka, and Lydie Meheus. 2018. “Omics-Driven Drug Repurposing as a Source of Innovative Therapies in Rare Cancers.” Expert Opinion on Orphan Drugs 6 (July): 513–17. doi:10.1080/21678707.2018.1500690.